Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis
Authors:
- Yoshitaka MoritaYMYoshitaka Morita
- Takeo SakutaTSTakeo Sakuta
- Atsunori KuwabaraAKAtsunori Kuwabara
- Naoki KashiharaNKNaoki Kashihara
- 19 October 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 17 (5) , 385-390
Abstract
Lower adiponectin levels in circulation are shown to be associated with endothelial dysfunction, which is a crucial feature in the evolution of atherosclerosis. The aim of our study is to evaluate ...Keywords
This publication has 28 references indexed in Scilit:
- Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant‐induced arthritisArthritis & Rheumatism, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritisRheumatology, 2005
- Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-αAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti–tumor necrosis factor α antibodyArthritis Care & Research, 2004
- Endothelial FunctionCirculation, 2004
- Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial CellsJournal of Biological Chemistry, 2003
- Association of Hypoadiponectinemia With Impaired VasoreactivityHypertension, 2003
- Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation, 2002
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994